Gait and Balance Function Improves After 10 Weeks of Using a Wearable Sensory Neuroprosthesis in Persons with Peripheral Neuropathy and High Fall Risk – the walk2Wellness Trial
Authors:
- Lars Ie OddssonLOLars Ie Oddsson
- Teresa BissonTBTeresa Bisson
- Helen S CohenHCHelen S Cohen
- Laura JacobsLJLaura Jacobs
- Mohammad KhoshnoodiMKMohammad Khoshnoodi
- Doris KungDKDoris Kung
- Lewis A LipsitzLLLewis A Lipsitz
- Brad ManorBMBrad Manor
- Patricia McCrackenPMPatricia McCracken
- Yvonne RumseyYRYvonne Rumsey
- Diane M WrisleyDWDiane M Wrisley
- Sara R Koehler-McNicholasSKSara R Koehler-McNicholas
Preprint
Abstract
Background: Patients with sensory peripheral neuropathy (PN) commonly present with gait and balance problems increasing their risk of falls. The multi-site walk2Wellness trial investigates effects of long-term, home-based daily use of a wearable lower limb sensory neuroprosthesis on gait function, balance, quality of life and fall rates in a cohort of PN patients. The device (Walkasins®, RxFunction Inc., MN, USA) is designed to replace lost nerve function related to foot pressure sensation by providing directional tactile cues around the ankle reflecting foot pressure measurements during standing and walking activities. We hypothesized that previously shown short-term in-clinic improvements in gait and balance would be sustained after 10 weeks of use. Methods: Participants had a PN diagnosis with loss of plantar sensation associated with gait and balance problems, a Functional Gait Assessment (FGA) score <23 (cut-off for high fall risk), and ability to sense Leg Unit tactile stimuli. Clinical outcomes included FGA, Gait Speed, Timed Up&Go (TUG) and Four-Stage Balance Test. Patient-reported outcomes included Activities-Specific Balance Confidence (ABC) scale, Vestibular Disorders Activities of Daily Living Scale (VADL), PROMIS participation and satisfaction scores, pain rating, and falls. Evaluations were performed at baseline visit and after 2, 6, and 10 weeks. Subjects were not made aware of any changes in outcomes and no additional balance interventions were allowed. Results: Forty-five participants of 52 enrolled across four sites completed all in-clinic assessments. FGA scores improved from 15.0 at baseline to 19.1 at 10 weeks (p<0.000001), normal and fast gait speed from 0.86m/s to 0.95m/s (p<0.00005) and 1.24m/s to 1.33m/s (p<0.002), respectively, and TUG from 13.8s to 12.5s (p<0.012). Four-Stage Balance Test did not improve significantly. Several patient-reported outcomes were in normal range at baseline and remained largely unchanged. Interestingly, while FGA scores improved similarly across the baseline range, subjects with baseline ABC scores lower than 67% (cut-off for high fall risk) showed an increase in their ABC scores (from 49.9% to 59.3%, p<0.01), whereas subjects with baseline ABC scores above 67% showed a decrease (from 76.6% to 71.8%, p<0.019). Subjects who reported falls in the prior six months (n=25) showed a decrease in the number of fall-risk factors (from 5.1 to 4.3, p<0.023) as well as a decrease in fall rate from 13.8 to 7.4 falls/1000 days (p<0.014). Four subjects in the pre-study non-faller group (n=20) fell during the 10 weeks of the study. Conclusion: A wearable sensory neuroprosthesis may provide a new way to treat gait and balance problems and manage falls in high fall-risk patients with PN. Trial registration: ClinicalTrials.gov (# NCT03538756 )Keywords
All Related Versions
- Published version: Frontiers in Aging Neuroscience, 12.
This publication has 114 references indexed in Scilit:
- Efficacy of a Vibrotactile Neurofeedback Training in Stance and Gait Conditions for the Treatment of Balance DeficitsOtology & Neurotology, 2011
- Gait Speed and Survival in Older AdultsJAMA, 2011
- The Trajectory of Gait Speed Preceding Mild Cognitive ImpairmentArchives of Neurology, 2010
- Optimizing the Tracking of Falls in Studies of Older Participants: Comparison of Quarterly Telephone Recall With Monthly Falls Calendars in the MOBILIZE Boston StudyAmerican Journal of Epidemiology, 2010
- Biological, clinical, and ethical advances of placebo effectsThe Lancet, 2010
- The gait and balance of patients with diabetes can be improved: a randomised controlled trialDiabetologia, 2009
- Exercise and Physical Activity for Older AdultsMedicine & Science in Sports & Exercise, 2009
- Vibrotactile tilt feedback improves dynamic gait index: A fall risk indicator in older adultsGait & Posture, 2009
- Will My Patient Fall?JAMA, 2007
- The PHQ-9Journal of General Internal Medicine, 2001